ProCE Banner Activity

Optimizing Clinical Outcomes With CD38 Antibodies for Transplant-Ineligible Patients With NDMM


Download this slideset for a comprehensive review of the latest data on incorporating CD38 antibodies into the treatment of transplant-ineligible patients with newly diagnosed multiple myeloma.

Released: June 11, 2024

Expiration: June 10, 2025



Francesca Gay

Francesca Gay, MD, PhD

Associate Professor
Department of Molecular Biotechnology and Health Science
University of Torino
SC Ematologia 1
AOU Citta della Salute e della Scienza
Torino, Italy

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Sanofi.